M Holdings Securities, Inc. Cel Sci Corp Transaction History

M Holdings Securities, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 16, 2022	SELL	$2.58 - $4.99 $71,533 - $138,352	-27,726 Closed	0 $0
Q1 2022 May 24, 2022	BUY	$3.93 - $7.7 $1,965 - $3,850	500 Added 1.84%	27,726 $109,000
Q2 2021 Aug 19, 2021	BUY	$8.68 - $27.49 $42,098 - $133,326	4,850 Added 21.68%	27,226 $236,000
Q1 2021 May 12, 2021	BUY	$12.0 - $27.64 $268,512 - $618,472	22,376 New	22,376 $340,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.